ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HEMO Hemogenyx Pharmaceuticals Plc

1.641
-0.03 (-1.80%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.03 -1.80% 1.641 1.62 1.66 1.642 1.62 1.64 5,990,463 16:35:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.98M -0.0035 -4.63 18.5M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.67p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £18.50 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.63.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13376 to 13398 of 13400 messages
Chat Pages: 536  535  534  533  532  531  530  529  528  527  526  525  Older
DateSubjectAuthorDiscuss
12/4/2024
11:39
By tempted back in below 1.4
trying2trade
12/4/2024
09:59
biodefence still rumbling.



This issue may be on going so this gives Dr Sandler the opportunity to implement

a alternative supplier ?

dreamtwister
10/4/2024
14:28
Doing well innit
albert35911
09/4/2024
15:19
interesting link below, custom & off the shelf car-t manufacturing pro`s & cons ?

hemogenyx have chosen to go down the custom route,

dreamtwister
08/4/2024
20:54
FDA accepts Shorla’s oral liquid leukemia drug NDA

SH-201 is an oral liquid drug, making the treatment accessible to patients who may struggle with taking tablets or other dosage forms. It slows or stops the growth of certain forms of leukemia, including chronic myeloid leukemia and acute lymphoblastic leukemia.

The blood science is becoming more accessible & cost effective....㇮6;

Below the link gives a insight to the Car-t science.

dreamtwister
08/4/2024
09:05
well the cd38 therapy has been approved, Dr Sandler has now to bring cd19 to the clinical trials.
dreamtwister
07/4/2024
19:54
hxxps://www.biospace.com/article/biotech-bankruptcies-skyrocket/

Hemo next? bankruptcies skyrocket in biotech !! WHO OWNS HEMO CASINO SHARES !!?

marcus80
07/4/2024
18:12
Great news ! FDA allows expanded use of cell therapies for blood cancer
The drugs from Johnson & Johnson and Bristol Myers Squibb can be used to treat patients in the earlier stages of a type of blood cancer.

dreamtwister
05/4/2024
11:53
U.S. Application No. 17/133,448

Title: METHOD OF ELIMINATING HEMATOPOIETIC STEM CELLS/HEMATOPOIETIC
PROGENITORS (HSC/HP) IN A PATIENT USING BI-SPECIFIC ANTIBODIES
Applicant: HEMOGENYX LLC
Inventor: Vladislav Sandler
Issued as U.S. Patent No. 11,945,866 on April 2, 2024.

ashleyjv
05/4/2024
11:22
End of year results due 28/29th
dreamtwister
05/4/2024
11:15
Any reason why ?
john henry
05/4/2024
09:38
i can for-see a Drug shortage leading to costs rising due to the USA V CHINA Biodefence

Should congress pass the Legislation & it becomes Mandatory then i trust Dr Sandler has a plan B.

" The Consumer is Not the Customer !

dreamtwister
05/4/2024
09:13
https://www.londonstockexchange.com/news-article/APH/full-year-trading-update/16307097
blackhorse23
05/4/2024
08:30
No it appears to be that ashleyjv is spot on as it is now April [and the last day of the current tax year with the new tax year starting on Monday]
apotheki
04/4/2024
13:31
the security issues !The Fda have lifted the clinical hold but i find misleading

as Wuxi are the providers of the Lentivirus ?

dreamtwister
02/4/2024
12:54
reading the pharma rags this morning it brings sadness to see,

Redx's plans mirror those of C4X Discovery, which is also exiting AIM dissatisfied

with its lack of access to growth capital. I knowledge that Hemogenyx are listed

on the Main Market & the option to downgrade to the Aim market which would give

Hemogenyx Flexibility to raise further Equity or eclipse Redx/C4x with taking

the science private before a Hostile t/o with the present sultry share price or

Visa-versa spin off one of the other scientific platforms ! in the event of

Privatization Shareholder will receive a dividend should some financial Muscle

shows interest ?

dreamtwister
28/3/2024
15:13
Tax Year for Private Investors?
Hemo's was in December and hopefully the results are due to be next Month (April)

ashleyjv
28/3/2024
15:05
End of the trading month and quarter today - then just 4 trading days to the end of this tax year next week.

Reckon that ahead of the new tax year that next week could be better for small caps including of course Hemogenyx Pharmaceuticals

apotheki
28/3/2024
10:01
Tannedgirl…it’s doing well today yes.
albert35911
28/3/2024
10:00
Tannedgirl…230;if your brain exploded it wouldn’t mess up your hair.
albert35911
27/3/2024
21:59
24hr manufacturing ! yet to be tested in humans but proven in mouse models.



The on going bio-security.






Made in china ! Sounds plausible as they IPO the Data.

dreamtwister
27/3/2024
14:13
Not many suckers buying today,they must be getting wise.
albert35911
26/3/2024
13:44
Will Hemo spend Easter at 1.80p +
steveberyl
Chat Pages: 536  535  534  533  532  531  530  529  528  527  526  525  Older

Your Recent History

Delayed Upgrade Clock